Pathogenetic Features of Acute Coronary Syndrome in Patients with Covid-19

Clicks: 128
ID: 275803
2022
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #41 of 57 articles by views in International Journal of Health Systems and Medical Sciences

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The development of acute coronary syndrome (ACS) is caused by an acute discrepancy between the myocardial oxygen demand and its delivery. This mechanism is more associated with the progression of coronary atherosclerosis in combination with an inflammatory response, hypoxemia, procoagulant state of blood plasma and platelets. Patients with the new coronavirus infection COVID-19 (COronaVIrus Disease 2019), burdened by cardiovascular diseases and comorbid pathology, represent a high risk group for ACS. The purpose of study: To analyze the published literature, which reflects data on the development of ACS in patients with COVID-19, its pathogenesis, and features of the clinical course? Material and methods. The search for literary data was carried out using Google Scholar, PubMed, ScienceDirect and Cyberleninka services. The analysis included data from clinical guidelines for the management of patients with COVID-19, data from clinical trials, reports and systematic reviews. Results. This literature review summarizes and systematizes the data presented in modern scientific publications, highlights aspects of the clinical course and features of the pathogenetic mechanisms underlying ACS in patients with COVID-19. Conclusion. The pathogenesis of COVID-19 is inextricably linked with the widespread cytopathic effect of SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus 2, coronavirus 2, causing severe acute respiratory distress syndrome), the generation of a pathological uncontrolled immune response that causes systemic inflammation, as well as the implementation of procoagulant activation of the hemostasis system. In patients with COVID-19, along with the atherosclerotic process, these mechanisms significantly increase the risk of developing ACS and may worsen its course at the hospital stage.
Reference Key
M.2022internationalPathogenetic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Muhamedova M. M.;Ganieva Sh. Sh.;
Journal International Journal of Health Systems and Medical Sciences
Year 2022
DOI
448
URL
https://inter-publishing.com/index.php/IJHSMS/article/view/448
Keywords
myocardial infarction acute coronary syndrome covid-19 postcovid syndrome

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.